Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma, Ewing | 2 | 2023 | 116 | 0.850 |
Why?
|
| Bone Neoplasms | 3 | 2023 | 445 | 0.810 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2023 | 14 | 0.800 |
Why?
|
| Acrylamides | 1 | 2020 | 24 | 0.680 |
Why?
|
| p21-Activated Kinases | 1 | 2020 | 56 | 0.660 |
Why?
|
| Aminopyridines | 1 | 2020 | 55 | 0.660 |
Why?
|
| ras Proteins | 1 | 2020 | 146 | 0.640 |
Why?
|
| Pyrroles | 1 | 2020 | 183 | 0.610 |
Why?
|
| Pyrazoles | 1 | 2020 | 330 | 0.560 |
Why?
|
| Rhabdomyosarcoma | 1 | 2020 | 215 | 0.540 |
Why?
|
| Apoptosis | 4 | 2020 | 1904 | 0.520 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 1540 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 2064 | 0.390 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1683 | 0.370 |
Why?
|
| Glioblastoma | 2 | 2012 | 374 | 0.290 |
Why?
|
| STAT3 Transcription Factor | 2 | 2012 | 232 | 0.280 |
Why?
|
| Adenovirus E1A Proteins | 2 | 2003 | 10 | 0.250 |
Why?
|
| Endoglin | 1 | 2025 | 32 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 1047 | 0.240 |
Why?
|
| HMGB1 Protein | 2 | 2003 | 26 | 0.210 |
Why?
|
| Transcription Factor TFIIA | 1 | 2003 | 1 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2025 | 998 | 0.200 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2023 | 37 | 0.200 |
Why?
|
| Sarcoma | 1 | 2025 | 209 | 0.200 |
Why?
|
| Mice | 7 | 2025 | 18565 | 0.180 |
Why?
|
| Neoplasms | 1 | 2016 | 2952 | 0.180 |
Why?
|
| Animals | 10 | 2025 | 34951 | 0.180 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 1425 | 0.170 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 1828 | 0.170 |
Why?
|
| Osteosarcoma | 1 | 2023 | 263 | 0.170 |
Why?
|
| Cell Movement | 2 | 2020 | 891 | 0.160 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2025 | 898 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2512 | 0.140 |
Why?
|
| Radiation Tolerance | 1 | 2018 | 64 | 0.140 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 1758 | 0.130 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2008 | 54 | 0.130 |
Why?
|
| Drug Synergism | 1 | 2016 | 234 | 0.130 |
Why?
|
| Necrosis | 1 | 2016 | 210 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2023 | 917 | 0.120 |
Why?
|
| Receptor, Insulin | 1 | 2015 | 68 | 0.120 |
Why?
|
| Metformin | 1 | 2015 | 165 | 0.100 |
Why?
|
| Cyanoacrylates | 1 | 2012 | 12 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 816 | 0.090 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 60 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2012 | 757 | 0.090 |
Why?
|
| Pyridines | 1 | 2012 | 249 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 1292 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 348 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 101 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 273 | 0.070 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 383 | 0.070 |
Why?
|
| Humans | 10 | 2025 | 132083 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 257 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 308 | 0.060 |
Why?
|
| TATA Box | 2 | 2003 | 16 | 0.060 |
Why?
|
| TATA-Box Binding Protein | 2 | 2003 | 31 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2015 | 4725 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2008 | 927 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2008 | 1569 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3698 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 701 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2023 | 17 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 161 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 147 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2682 | 0.050 |
Why?
|
| Disease Progression | 1 | 2008 | 2224 | 0.050 |
Why?
|
| High Mobility Group Proteins | 1 | 2000 | 33 | 0.040 |
Why?
|
| Binding Sites | 1 | 2003 | 1256 | 0.040 |
Why?
|
| Child | 1 | 2020 | 25761 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 688 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 4694 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 67 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 170 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 134 | 0.030 |
Why?
|
| Male | 2 | 2020 | 64904 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 274 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 663 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 311 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 446 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2000 | 1050 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 503 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2012 | 133 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1085 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 806 | 0.020 |
Why?
|
| Female | 2 | 2025 | 70664 | 0.010 |
Why?
|
| Transcription Factor TFIIB | 1 | 2000 | 5 | 0.010 |
Why?
|
| Transcription Factors, TFII | 1 | 2000 | 7 | 0.010 |
Why?
|
| Transcription Factor TFIID | 1 | 2000 | 17 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 276 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2000 | 142 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 571 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 430 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 999 | 0.010 |
Why?
|
| Protein Binding | 1 | 2000 | 1735 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2000 | 995 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1997 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2000 | 2494 | 0.010 |
Why?
|